MGRX

Mangoceuticals Inc

0.1892

Nov 10 • 3:59 PM ET -0.0078 (-3.96%)

0.1940

Aftermarket • 5:47 PM ET +0.0048 (2.54%)

Healthcare Health Information Services USA Nano NASD

Peers: LFMD HIMS MNDR TDOC BTMD DRIO AMWL GDRX WW NNE

| Held by: VXF

Scroll to Statements

Index	-
Market Cap	4.21M
Enterprise Value	4.30M
Income	-15.99M
Sales	0.32M
Book/sh	0.70
Cash/sh	0.01
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	3
IPO	Mar 21, 2023

P/E	-
Forward P/E	-
PEG	-
P/S	13.15
P/B	0.27
P/C	18.29
P/FCF	-
EV/EBITDA	-
EV/Sales	13.43
Quick Ratio	0.18
Current Ratio	0.18
Debt/Eq	0.03
LT Debt/Eq	0.02
Option/Short	No / Yes

EPS (ttm)	-1.17
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-7.77% -244.95%
Sales past 3/5Y	270.88% -
EPS Y/Y TTM	63.25%
Sales Y/Y TTM	-38.91%
EPS Q/Q	82.71%
Sales Q/Q	-59.10%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	21.25%
Insider Trans	0.00%
Inst Own	7.84%
Inst Trans	10.57%
ROA	-85.72%
ROE	-94.42%
ROIC	-118.21%
Gross Margin	-384.90%
Oper. Margin	-4272.95%
Profit Margin	-5071.14%
SMA20	-23.61%
SMA50	-46.57%
SMA200	-52.07%
Trades

Shs Outstand	18.02M
Shs Float	17.50M
Short Float	0.30%
Short Ratio	0.04
Short Interest	0.05M
52W High	2.41 -92.15%
52W Low	0.16 16.79%
Volatility	14.94% 13.74%
ATR (14)	0.03
RSI (14)	27.31
Beta	2.18
Rel Volume	0.19
Avg Volume	1.39M
Volume	262,622

Perf Week	-13.21%
Perf Month	-50.65%
Perf Quarter	-64.50%
Perf Half Y	-45.24%
Perf YTD	-74.43%
Perf Year	-90.95%
Perf 3Y	-97.20%
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	0.20
Price	0.19
Change %	-3.96%

Oct-09-26 04:01PM	Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close (GlobeNewswire) -9.15%
Oct-01-26 03:50PM	Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche (GlobeNewswire) +12.24%
Aug-13-26 04:05PM	Mangoceuticals Inc.'s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets (GlobeNewswire)
Aug-06-26 07:00AM	Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure (GlobeNewswire) +23.85%
Aug-05-26 04:05PM	Mangoceuticals' Merger Partner, Nuclea Energy ("Nuclea"), Executes MOU with Utah Office of Energy Development (GlobeNewswire) -7.10%
04:05PM	Loading…
Aug-04-26 04:05PM	Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination (GlobeNewswire) -14.55%
Jul-30-26 10:35AM	Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor (Newsfile) -46.88%
07:00AM	Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology (GlobeNewswire)
Mar-17-26 04:00PM	Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. (GlobeNewswire) -6.95%
Mar-06-26 04:00PM	Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds (GlobeNewswire) -7.02%
Feb-23-26 04:05PM	Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study (GlobeNewswire)
Feb-20-26 03:40PM	Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally? (Benzinga) +48.83%
09:59AM	Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model (Benzinga)
Feb-19-26 04:05PM	MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program (GlobeNewswire)
Dec-19-25 12:32PM	Big Move In Solana: 2 Reasons Why This Top Token Surged 7% Off Yesterday's Bottom (Motley Fool) -45.57%
10:38AM	Loading…
10:38AM	Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements (GlobeNewswire)
07:30AM	Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy (GlobeNewswire)
Dec-18-25 08:30AM	Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules (GlobeNewswire) +7.38%
Nov-14-25 08:00AM	Eli Lilly and Novo Nordisk disown Mangoceuticals GLP-1RA partnership claim (Pharmaceutical Technology) +24.37%
Nov-13-25 07:37PM	Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs (GlobeNewswire) -32.39%
07:00AM	Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management (GlobeNewswire)
May-28-25 09:15AM	Mangoceuticals shares results from field studies on MGX-0024 (TipRanks) +11.64%
May-27-25 09:00AM	Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu (GlobeNewswire) +11.83%
Apr-28-25 05:36AM	ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market (Newsfile)
Apr-25-25 09:00AM	Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division (GlobeNewswire) -13.81%
Apr-22-25 01:55PM	CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape (ACCESSWIRE) -10.04%
Mar-25-25 09:00AM	Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol in the USA and Canada (GlobeNewswire) -40.84%
Feb-20-25 07:00AM	Mangoceuticals Announces the Launch of PeachesRx - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments (GlobeNewswire) -15.71%
Feb-12-25 08:00AM	Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution (GlobeNewswire)
Feb-06-25 07:00AM	Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research (GlobeNewswire) +7.89%
08:30AM	Loading…
Feb-03-25 08:30AM	Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol Skincare Treatment Targeting Hyperpigmentation (GlobeNewswire)
Dec-19-24 05:33PM	Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent (GlobeNewswire)
Dec-04-24 07:00AM	Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split (GlobeNewswire)
Oct-31-24 08:00AM	Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Oct-22-24 08:00AM	MangoRx Announces Formation of Strategy and Alternatives Committee (GlobeNewswire)
Oct-21-24 05:10PM	MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly (GlobeNewswire)
Oct-18-24 08:45AM	Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 (Newsfile)
Oct-12-24 05:20PM	Mangoceuticals announces 1-for-15 reverse stock split (TipRanks)
Oct-11-24 05:15PM	MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN (GlobeNewswire) -10.68%
Oct-03-24 08:30AM	MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions (GlobeNewswire) -11.27%
Oct-01-24 07:30AM	MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment (GlobeNewswire) +26.44%
Aug-15-24 09:25AM	MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024 (GlobeNewswire)
Aug-13-24 04:00PM	MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent (GlobeNewswire) +9.61%
Aug-09-24 08:15AM	MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide (GlobeNewswire) -13.96%
Aug-08-24 08:30AM	MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market (ACCESSWIRE)
Jul-25-24 06:00AM	Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future (News Direct)
Jul-24-24 08:15AM	MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology (GlobeNewswire)
Jul-18-24 04:05PM	Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access (GlobeNewswire) -8.04%
Jul-16-24 08:20AM	MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts (GlobeNewswire) +11.46%
Jul-12-24 01:30PM	MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department (GlobeNewswire) +7.25%
Jul-11-24 08:15AM	MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets (GlobeNewswire) +6.45%
Jun-06-24 08:30AM	MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology (GlobeNewswire)
Jun-04-24 04:00PM	MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies (GlobeNewswire) +6.00% +6.87%
08:00AM	MangoRx to Introduce MOJO Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances (GlobeNewswire)
May-28-24 08:30AM	Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets (GlobeNewswire) +7.00%
07:27AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-23-24 09:45AM	MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts (ACCESSWIRE) +13.04%
May-22-24 07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) -10.73%
May-21-24 04:00PM	Why Is Mangoceuticals (MGRX) Stock Up 130% Today? (InvestorPlace) +103.68%
08:30AM	MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications (GlobeNewswire)
May-16-24 09:53PM	MGRX Stock Earnings: Mangoceuticals Reported Results for Q1 2024 (InvestorPlace) +9.50%
04:40PM	MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration (GlobeNewswire)
May-02-24 08:00AM	Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement (GlobeNewswire)
Apr-25-24 08:30AM	Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care (GlobeNewswire)
Apr-12-24 08:45AM	Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products (GlobeNewswire) -9.93%
Mar-12-24 09:00AM	MangoRx Officially Launches 'PRIME' by MangoRx, Powered by Kyzatrex FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment (GlobeNewswire)
Feb-20-24 09:00AM	MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth (GlobeNewswire)
Feb-13-24 08:00AM	MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY (GlobeNewswire) -13.39%
Feb-06-24 09:00AM	MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE SPIRITS (GlobeNewswire) +6.51%
Feb-05-24 08:50AM	MangoRx Accepting Pre Orders for its PRIME , by MangoRx, Powered by Kyzatrex FDA Approved Oral Testosterone Replacement Therapy (TRT) Product (GlobeNewswire) -7.01%
Jan-19-24 08:00AM	MangoRx's Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11 (GlobeNewswire)
Dec-15-23 10:39AM	Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering (GlobeNewswire) -40.97%
09:29AM	Why Is Mangoceuticals (MGRX) Stock Down 33% Today? (InvestorPlace)
Dec-13-23 07:30AM	MANGOCEUTICALS TO INTRODUCE PRIME , POWERED BY KYZATREX (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT (GlobeNewswire)
Dec-06-23 08:00AM	Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America (GlobeNewswire)
Nov-29-23 08:30AM	Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider (GlobeNewswire) +17.61%
Nov-16-23 08:30AM	Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx (ACCESSWIRE)
Nov-02-23 09:15AM	Mangoceuticals, Inc. Launches Charitable Initiative in Support of Men's Health Awareness Month (GlobeNewswire) -10.75%
Oct-26-23 07:30AM	Mangoceuticals Launches TikTok Influencer Initiative and Becomes the Presenting Sponsor of the Only Stans Podcast with Glenny Balls (GlobeNewswire) +8.57%
Oct-19-23 09:00AM	Mangoceuticals, Inc. Provides Update to Shareholders on Q3 Achievements and Guidance on Year End and Near-Term Initiatives (GlobeNewswire) +25.00%
Oct-13-23 09:40AM	Mangoceuticals Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Bloomberg TV and Fox Business (GlobeNewswire)
09:12AM	New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network (GlobeNewswire)
Oct-12-23 09:15AM	Mangoceuticals Announces the Official Launch of MangoRx Affiliate Marketing Program to Enhance and Accelerate Topline Growth (GlobeNewswire) -8.03%
Sep-14-23 06:00AM	Mangoceuticals Brand MangoRx Announced as Raindance Film Festivals Headline Sponsor (GlobeNewswire)
Sep-08-23 10:38AM	UPDATE: New to The Street Proudly Announces its 500th Special Edition 1-hour Broadcast with Guest Appearances, Airs on Newsmax, Saturday, September 9, 2023, 3:00-4:00 PM ET (GlobeNewswire) +5.30%
09:30AM	New to The Street Proudly Announces its 500th Special Edition 1-hour Broadcast with Guest Appearances, Airs on Newsmax, Saturday, September 9, 2023, 3:30 PM ET (GlobeNewswire)
Sep-07-23 08:00AM	Mangoceuticals Expands its Nationwide Marketing Efforts with a Multiplatform Audio Powerhouse Across America (GlobeNewswire)
Aug-30-23 08:00AM	Mangoceuticals Launches New High-Production Quality Ad Providing Fresh Insight into its Proprietary Mango Erectile Dysfunction Pill Formula (GlobeNewswire)
Aug-16-23 08:00AM	Mangoceuticals Launches New Sildenafil Based Erectile Dysfunction Product with Signature Mango Flavor & Rapid Dissolve (GlobeNewswire)
Aug-09-23 08:00AM	Mangoceuticals Partners with Greater NY Chamber of Commerce for Mass Marketing & Sales of Flagship Mango Product (GlobeNewswire)
Aug-02-23 08:00AM	Mangoceuticals, Inc. Names Award Winning Globally Recognized Lucky Break PR as Public Relations Firm (GlobeNewswire)
Aug-01-23 08:00AM	Mangoceuticals Engages Premier Global Software Development Firm, RedLime Solutions to Expand Technology Platform to Accommodate Increased Customer Flow (GlobeNewswire) +28.32%
Jul-27-23 08:00AM	Mangoceuticals, Inc. Adds Top Mens Podcast, Pillow Talk with Ryan Pownall, to Sponsorship Portfolio (GlobeNewswire) -5.17%
Jul-24-23 10:47AM	New to The Street TV Announces Episode 491 with its Five Business Guest Interviews, Airs on FOX Business Network, Tonight, July 24, 2023, at 10:30 PM PT (GlobeNewswire) -7.17%
Jul-21-23 09:30AM	New to The Street Announces its Five Corporate Interviews, Episode 490, Airing on Newsmax, Saturday, July 22, 2023, at 3:30 PM ET (GlobeNewswire)
Jul-18-23 10:00AM	Mangoceuticals Engaged by Social Media Sensation Adam22 as Exclusive New Sponsor of Hit Podcasts with Skyrocketing Male Engagement (GlobeNewswire)
Jul-12-23 10:00AM	Mangoceuticals, Inc. Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Fox Business, Bloomberg TV, and Newsmax TV (GlobeNewswire)
Jun-29-23 10:00AM	Mangoceuticals Collaborates with Ice Shaker to Launch Mango Branded Ice Shaker Protein Bottles on MakeAmericaHardAgain.com (ACCESSWIRE)
Jun-27-23 10:00AM	Mangoceuticals Launches Make America Hard Again Campaign & Merchandise Website (GlobeNewswire) -5.43%
Jun-22-23 10:30AM	Mangoceuticals CEO to Feature in Upcoming Interview at Nasdaq MarketSite Studio on Fox Business, Bloomberg TV, and Newsmax TV (GlobeNewswire) +9.94%

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JOHNSTON EUGENE M	CFO	Dec 15 '25	Sale	1.17	3,333	3,884	120,000	Dec 17 05:00 PM
JOHNSTON EUGENE M	CFO	Dec 09 '25	Sale	1.20	5,000	5,975	123,333	Dec 11 04:05 PM
JOHNSTON EUGENE M	CFO	Dec 05 '25	Sale	1.13	10,000	11,280	128,333	Dec 09 05:16 PM
JOHNSTON EUGENE M	Officer	Dec 03 '25	Proposed Sale	1.16	128,333	148,866		Dec 03 10:03 AM
Hamilton Alex P.	Director	Nov 19 '25	Sale	1.22	125,000	152,875	3,334	Nov 26 04:30 PM
Hamilton Alex P.	Director	Nov 19 '25	Proposed Sale	1.24	125,000	155,125		Nov 19 11:46 AM

Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.

Co-FounderMr. Jacob D. Cohen

Chief Financial OfficerMr. Eugene M. Johnston

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MGRX

Mangoceuticals Inc

Upgrade your Finviz experience